Medicare finalizes new drug pricing model for office-administered medications
The Hill · October 1, 2026Original source ↗
What happened
The Trump administration has introduced the final version of a Medicare payment model designed to adjust the prices of drugs administered in doctors' offices. The new model aims to bring these prices in line with those paid in other countries.
Why it matters
This change may impact drug costs for patients receiving treatments in outpatient settings.
How this story affects people
How does this story affect you if you receive outpatient treatments?
This change could lower the costs of medications you receive in a doctor's office, making treatments more affordable. Patients may benefit from prices that align more closely with those in other countries.
Read a briefing based on your profile
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Download on the App Store3 free Ripples in total. Read without an account. iPhone · iOS 26.0+ · United States
More stories
- HealthMeasles outbreak in Pennsylvania affects pregnancy care practices
- HealthKenya reports first Ebola case following death of man returning from DRC
- HealthU.S. Response to Potential Plague Threat in Russia Delayed by Missing Details
- HealthBryan Johnson discusses his autoimmune diagnosis and public reaction